Xcout Intel
Infinitopes competitors & alternatives
The 12 closest competitors and alternatives to Infinitopes among healthcare companies — ranked by similarity to what Infinitopes actually does, not by market-cap band.
Subscribe to see Infinitopes’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Infinitopes
Infinitopes is a biotechnology research company based in Oxford, United Kingdom, focused on developing revolutionary off-the-shelf precision vaccines to prevent deaths from cancer metastases.
Infinitopes at a glance
Infinitopes is a healthcare company headquartered in United Kingdom. Its most recent funding round, Seed, raised $35M in January 2026. Xcout tracks 8 named people at Infinitopes, including Dan Menichella (Interim Chief Executive Officer).
Infinitopes leadership
- Dan MenichellaInterim Chief Executive Officer
- Jonathan KwokChief Executive Officer
- Jo BrewerChief Scientific Officer & Interim Chief Operating Officer
- Jonathan KwokCo-Founder, President & Chief Medical Officer
- Lian Ni LeeVP IMMUNOLOGY & CO-FOUNDER
- Elliot HershbergPartner, Amplify Partners
2 more named people on record for Infinitopes, with roles, board committees and tenure — see the full roster →
Infinitopes funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $35M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Infinitopes competitors
Ranked by semantic similarity — how close each company is to Infinitopes by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
Similar healthcare company
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Biotechnology
Epitopea is a transatlantic cancer immunotherapeutics company operating from Montreal, Canada, and Cambridge, United Kingdom. Backed by life-science investors, the company develops novel therapeutics utilizing its proprietary CryptoMap platform.
Biotech
Enara Bio, Ltd. is a UK biotechnology company that discovers cancer targets, including tumor-specific antigens, using immunopeptidomics and machine-learning technologies. It works with biopharmaceutical companies to support development of cancer vaccines and other targeted immunotherapies.
Biotechnology
OneChain Immunotherapeutics is a biotechnology company based in Barcelona focused on the development of CAR-T cell therapies and in vivo platforms for cancer immunotherapy.
Biotech
iLoF is a biotechnology research company pioneering AI-powered photonics solutions for personalized healthcare and drug discovery, headquartered in London.
Biotech
Altamira Therapeutics Ltd. is a biotechnology company developing RNA-based cancer therapies using its proprietary xPhore nanoparticle delivery technology. Its lead candidate, ATX-402, is designed to systemically deliver therapeutic mRNA to reprogram the tumor microenvironment and improve cancer immunotherapy outcomes for patients.
Biotechnology
Neogap Therapeutics is a privately held clinical-stage biopharmaceutical company founded in 2016 and located at the Cancer Center Karolinska in Stockholm, Sweden. The company focuses on immuno-oncology and is developing personalized therapies for cancer treatment.
Biotechnology
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Biotech
Aptose Biosciences Inc. is a clinical-stage biotechnology company that develops small molecule cancer therapeutics, focusing on precision medicines for hematologic malignancies. The company's product pipeline features investigational drug candidates such as tuspetinib and luxeptinib, which are designed to treat conditions like acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and B-cell malignancies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Infinitopes and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Infinitopesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →